CELARES
The outstanding growth of the pharmaceutical biotechnology industry means new challenges for classical pharmaceutical companies. Especially big companies often lack the capability, flexibility, and required speed of operation to develop the necessary technological know-how for the formulation of biopharmaceuticals within the company.
CELARES
Social Links:
Industry:
Biotechnology Pharmaceutical
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.celares.com
Status:
Active
Contact:
+ 49 (0) 30 94 89 23 50
Email Addresses:
[email protected]
Similar Organizations
BIOMM
BIOMM engages in the biotechnology industry.
geneOmbio
geneOmbio is a pharmaceutical and biotechnology company.
Project Support
Project Support is a consulting services to the pharmaceutical and biotechnology industry.
Spero Oncology
Spero Oncology is a pharmaceutical, biotechnology and medical device firm.
Official Site Inspections
http://www.celares.com
- Host name: 91-203-75-115.dc7.ccsleeds.co.uk
- IP address: 91.203.75.115
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Celares"
Company - Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The …See details»
Fully Automated, Scalable, Cell Therapy Manufacturing - Cellares
Purpose-built Technology Powers the First Integrated Development & Manufacturing Organization (IDMO) Reagent Vault System (RVS) Capacity for up to 200 automation-friendly reagent …See details»
Celares - Crunchbase Company Profile & Funding
Celares is a pharmaceutical biotechnology industry means new challenges for classical pharmaceutical companies. Especially big companies often lack the …See details»
Cellares - LinkedIn
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century.See details»
Cellares 2025 Company Profile: Valuation, Funding & Investors
Operator of an Integrated Development and Manufacturing Organization committed to accelerating patients' access to life-saving cell therapies. The company is developing and …See details»
celares 2025 Company Profile: Valuation, Investors, …
Celares General Information Description. Developer of conjugate vaccines and bioconjugate drugs intended to serve diagnostic and pharmaceutical companies. The company GMP production of bioconjugates and functionalized polymers …See details»
Cellares Raises $255M Series C to Launch First …
Aug 23, 2023 Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is ...See details»
Inside the futuristic biotech startup Cellares that’s …
5 days ago Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in fundingSee details»
Cellares - Work in biotech
The Shuttle is a closed system enabling a 70% cost reduction and a 3-fold reduction in failure rates. Customers can design and monitor their cell therapy production with the Cellares …See details»
Celares GmbH - Life-Sciences-Europe.com
Jan 1, 2003 celares GmbH is focused on development and manufacturing of polymer-based drug delivery excipients and bioconjugate drugs. Established in 2003 and based in Berlin, …See details»
Celares - pharmaceutical-tech.com
Celares GmbH is a privately owned company, established in 2003, and a recognized leader in the field of bioconjugation/half-life extension by chemical modification and the synthesis of …See details»
Cellares Raises $255M Series C to Launch First Integrated …
SOUTH SAN FRANCISCO, August 23, 2023 – Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy …See details»
More documents for Biosynth (since 9/22) (Group) - Life-Sciences …
Established in 2003 and based in Berlin, Germany, celares is a leader in the field of bioconjugation/half-life extension by chemical modification and the synthesis of specialty …See details»
Celares - Overview, News & Similar companies | ZoomInfo.com
Who is Celares. Celares GmbH, Berlin, Germany, a privately-owned company, is a recognized leader in the field of pegylation and chemical modification of biopharmac euticals. The …See details»
Celares - PharmaSource
Celares GmbH is a Contract Development and Manufacturing Organisation (CDMO) that specializes in the development and manufacturing of polymer-based drug delivery excipients …See details»
Bioconjugation and Specialty Polymers. - Biosynth
Jul 11, 2023 celares GmbH is focused on development and manufacturing of polymer-based drug delivery excipients and bioconjugate drugs. Established in 2003 and based in Berlin, …See details»
Cellares Announces Agreement with Kite to Evaluate Its Cell …
Jun 27, 2024 Cellares is the first Integrated Development and Manufacturing Organization (IDMO) that takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st …See details»
Biosynth Acquires Celares for Growing Conjugate Vaccine Market
Jul 12, 2023 “celares is an established leader in bioconjugation, and we are extremely excited to be acquiring such a great team of specialists. celares is a perfect complement to our wider …See details»
Biosynth Expands Capabilities with Acquisition of celares, Experts …
Established in 2003 and based in Berlin, Germany, celares is a leader in the field of bioconjugation/half-life extension by chemical modification and the synthesis of specialty …See details»